GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Catheter Precision Inc (AMEX:VTAK) » Definitions » Piotroski F-Score

Catheter Precision (Catheter Precision) Piotroski F-Score : 4 (As of May. 22, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Catheter Precision Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Catheter Precision has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Catheter Precision's Piotroski F-Score or its related term are showing as below:

VTAK' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 3   Max: 5
Current: 4

During the past 8 years, the highest Piotroski F-Score of Catheter Precision was 5. The lowest was 1. And the median was 3.


Catheter Precision Piotroski F-Score Historical Data

The historical data trend for Catheter Precision's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catheter Precision Piotroski F-Score Chart

Catheter Precision Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial 2.00 1.00 2.00 3.00 3.00

Catheter Precision Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 4.00 3.00 4.00

Competitive Comparison of Catheter Precision's Piotroski F-Score

For the Medical Devices subindustry, Catheter Precision's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Catheter Precision's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Catheter Precision's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was -1.576 + -1.927 + -0.669 + -2.675 = $-6.85 Mil.
Cash Flow from Operations was -4.847 + -1.83 + -1.889 + -1.942 = $-10.51 Mil.
Revenue was 0.096 + 0.133 + 0.128 + 0.082 = $0.44 Mil.
Gross Profit was 0.089 + 0.127 + 0.121 + 0.077 = $0.41 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(48.509 + 35.542 + 32.871 + 30.736 + 28.021) / 5 = $35.1358 Mil.
Total Assets at the begining of this year (Mar23) was $48.51 Mil.
Long-Term Debt & Capital Lease Obligation was $0.09 Mil.
Total Current Assets was $1.95 Mil.
Total Current Liabilities was $2.35 Mil.
Net Income was -8.448 + -4.763 + -8.159 + -66.4 = $-87.77 Mil.

Revenue was 0.005 + 0 + 0 + 0.085 = $0.09 Mil.
Gross Profit was -0.061 + 0 + 0 + 0.075 = $0.01 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(23.747 + 14.373 + 17.471 + 16.836 + 48.509) / 5 = $24.1872 Mil.
Total Assets at the begining of last year (Mar22) was $23.75 Mil.
Long-Term Debt & Capital Lease Obligation was $0.09 Mil.
Total Current Assets was $12.76 Mil.
Total Current Liabilities was $4.45 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Catheter Precision's current Net Income (TTM) was -6.85. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Catheter Precision's current Cash Flow from Operations (TTM) was -10.51. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=-6.847/48.509
=-0.14114907

ROA (Last Year)=Net Income/Total Assets (Mar22)
=-87.77/23.747
=-3.69604582

Catheter Precision's return on assets of this year was -0.14114907. Catheter Precision's return on assets of last year was -3.69604582. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Catheter Precision's current Net Income (TTM) was -6.85. Catheter Precision's current Cash Flow from Operations (TTM) was -10.51. ==> -10.51 <= -6.85 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=0.087/35.1358
=0.00247611

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=0.088/24.1872
=0.00363829

Catheter Precision's gearing of this year was 0.00247611. Catheter Precision's gearing of last year was 0.00363829. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=1.954/2.35
=0.83148936

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=12.756/4.453
=2.86458567

Catheter Precision's current ratio of this year was 0.83148936. Catheter Precision's current ratio of last year was 2.86458567. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Catheter Precision's number of shares in issue this year was 7.429. Catheter Precision's number of shares in issue last year was 2.726. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.414/0.439
=0.94305239

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.014/0.09
=0.15555556

Catheter Precision's gross margin of this year was 0.94305239. Catheter Precision's gross margin of last year was 0.15555556. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=0.439/48.509
=0.00904987

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=0.09/23.747
=0.00378995

Catheter Precision's asset turnover of this year was 0.00904987. Catheter Precision's asset turnover of last year was 0.00378995. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+1+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Catheter Precision has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Catheter Precision  (AMEX:VTAK) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Catheter Precision Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Catheter Precision's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Catheter Precision (Catheter Precision) Business Description

Traded in Other Exchanges
Address
1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708
Catheter Precision Inc Formerly Ra Medical Systems Inc is a commercial-stage medical device company whose business comprises of the design, manufacture and sale of new medical technologies in the field of cardiac electrophysiology, or EP. Its product, View into Ventricular Onset System or VIVO System which is a non invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. . It operates business as one segment which includes all activities related to the marketing, sales and development of medical technologies in the field of cardiac EP.
Executives
David A Jenkins director, officer: Executive Chairman of Board P.O. BOX 682838, PARK CITY UT 84068
Steven K Passey officer: Chief Financial Officer 3216 SOUTH HIGHLAND DRIVE, SUITE 200, SALT LAKE CITY UT 84117
James Joseph Caruso director 28 FIRST AVE, SEASIDE PARK NJ 08752
Brian Conn officer: Chief Financial Officer MICROISLET, INC., 6370 NANCY RIDGE DRIVE, SUITE 112, SAN DIEGO CA 92121
Andrew C. Jackson officer: CFO & Secretary 11988 EL CAMINO REAL STE. 650, SAN DIEGO CA 92130
Jonathan Will Mcguire director, officer: Chief Executive Officer 96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Susanne Meline director P.O. BOX 515381, #86506, LOS ANGELES CA 90051
Martin J Colombatto director
Richard Jr Mejia director 2200 FARADAY AVENUE, SUITE 100, CARLSBAD CA 92008
William R Enquist director 11810 WILLS ROAD, ALPHARETTA GA 30009
Joan Stafslien director CAREFUSION CORPORATION, 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Daniel Horwood officer: General Counsel C/O RA MEDICAL SYTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011
Jeffrey J Kraws officer: Co-President 3985 RESEARCH PARK DRIVE, ANN ARBOR MI 48108
Dean Irwin director, 10 percent owner, officer: See Remarks C/O RA MEDICAL SYSTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011
Martin Burstein 10 percent owner C/O RA MEDICAL SYSTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011